Newsletter
Precision in Diagnostics – Worlwide
Medipan & GA Generic Assays develop cutting-edge in-vitro diagnostics for autoimmune and infectious diseases. With 30+ years of expertise, we provide advanced IFA, LINE/Dot Immunoblot, RIA, ELISA and Lateral Flow technologies to labs and clinics in 60+ countries—enhancing diagnostics and patient care.
Contents
We inform you about current topics and developments in the field of diagnostics, with special focus on autoimmune diagnostics, as well as exclusive insights, and the latest innovative diagnostics from Medipan & GA Generic Assays.
Double opt-in and opt-out
You will receive a double opt-in e-mail in which you will be asked to confirm your registration. You can object to receiving the newsletter at any time (opt-out). You will find a link to unsubscribe in every newsletter or in the double opt-in email.
Newsletter mailing frequency
The newsletter is sent out approx. once a month. The frequency depends on the current market situation, relevance of the topics and developments in the area of diagnostics
Data protection information
You can find detailed information on the sending procedure and statistics as well as your opt-out options in our Medipan’s Private Policy and GA Generic Assay’s Privacy Policy.
Use of GetResponse
The newsletter is sent using “GetResponse”, which also stores the email addresses and other information for sending and analyzing the newsletter.